vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and StoneX Group Inc. (SNEX). Click either name above to swap in a different company.
StoneX Group Inc. is the larger business by last-quarter revenue ($1.2B vs $617.8M, roughly 1.9× Hims & Hers Health, Inc.). StoneX Group Inc. runs the higher net margin — 11.6% vs 3.3%, a 8.2% gap on every dollar of revenue. On growth, StoneX Group Inc. posted the faster year-over-year revenue change (81.0% vs 28.4%). Hims & Hers Health, Inc. produced more free cash flow last quarter ($-2.5M vs $-1.3B). Over the past eight quarters, StoneX Group Inc.'s revenue compounded faster (53.5% CAGR vs 49.0%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
StoneX Group Inc. is an American financial services company. The company operates in six areas: commercial hedging, global payments, securities, physical commodities, foreign exchange and clearing and execution services (CES).
HIMS vs SNEX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $617.8M | $1.2B |
| Net Profit | $20.6M | $139.0M |
| Gross Margin | 71.9% | — |
| Operating Margin | 1.5% | 15.4% |
| Net Margin | 3.3% | 11.6% |
| Revenue YoY | 28.4% | 81.0% |
| Net Profit YoY | -20.8% | 63.3% |
| EPS (diluted) | $0.08 | $2.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $617.8M | $1.2B | ||
| Q3 25 | $599.0M | $32.7B | ||
| Q2 25 | $544.8M | $851.2M | ||
| Q1 25 | $586.0M | $820.4M | ||
| Q4 24 | $481.1M | $663.1M | ||
| Q3 24 | $401.6M | $31.1B | ||
| Q2 24 | $315.6M | $571.8M | ||
| Q1 24 | $278.2M | $509.2M |
| Q4 25 | $20.6M | $139.0M | ||
| Q3 25 | $15.8M | $85.7M | ||
| Q2 25 | $42.5M | $63.4M | ||
| Q1 25 | $49.5M | $71.7M | ||
| Q4 24 | $26.0M | $85.1M | ||
| Q3 24 | $75.6M | $76.7M | ||
| Q2 24 | $13.3M | $61.9M | ||
| Q1 24 | $11.1M | $53.1M |
| Q4 25 | 71.9% | — | ||
| Q3 25 | 73.8% | 3.7% | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 73.5% | — | ||
| Q4 24 | 76.8% | — | ||
| Q3 24 | 79.2% | 3.0% | ||
| Q2 24 | 81.3% | — | ||
| Q1 24 | 82.4% | — |
| Q4 25 | 1.5% | 15.4% | ||
| Q3 25 | 2.0% | 0.3% | ||
| Q2 25 | 4.9% | -1.3% | ||
| Q1 25 | 9.9% | -1.0% | ||
| Q4 24 | 3.9% | -3.2% | ||
| Q3 24 | 5.6% | -0.0% | ||
| Q2 24 | 3.5% | -4.7% | ||
| Q1 24 | 3.6% | -2.5% |
| Q4 25 | 3.3% | 11.6% | ||
| Q3 25 | 2.6% | 0.3% | ||
| Q2 25 | 7.8% | 7.4% | ||
| Q1 25 | 8.4% | 8.7% | ||
| Q4 24 | 5.4% | 12.8% | ||
| Q3 24 | 18.8% | 0.2% | ||
| Q2 24 | 4.2% | 10.8% | ||
| Q1 24 | 4.0% | 10.4% |
| Q4 25 | $0.08 | $2.50 | ||
| Q3 25 | $0.06 | $0.72 | ||
| Q2 25 | $0.17 | $1.22 | ||
| Q1 25 | $0.20 | $1.41 | ||
| Q4 24 | $0.10 | $1.69 | ||
| Q3 24 | $0.32 | $2.32 | ||
| Q2 24 | $0.06 | $1.25 | ||
| Q1 24 | $0.05 | $1.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | $1.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $540.9M | $2.5B |
| Total Assets | $2.2B | $47.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $228.6M | $1.6B | ||
| Q3 25 | $345.8M | $1.6B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $273.7M | $1.3B | ||
| Q4 24 | $220.6M | $1.4B | ||
| Q3 24 | $165.5M | $1.3B | ||
| Q2 24 | $129.3M | $1.2B | ||
| Q1 24 | $105.2M | $1.3B |
| Q4 25 | $540.9M | $2.5B | ||
| Q3 25 | $581.0M | $2.4B | ||
| Q2 25 | $562.7M | $2.0B | ||
| Q1 25 | $549.3M | $1.9B | ||
| Q4 24 | $476.7M | $1.8B | ||
| Q3 24 | $440.1M | $1.7B | ||
| Q2 24 | $362.0M | $1.6B | ||
| Q1 24 | $344.5M | $1.5B |
| Q4 25 | $2.2B | $47.8B | ||
| Q3 25 | $2.2B | $45.3B | ||
| Q2 25 | $1.9B | $34.3B | ||
| Q1 25 | $891.7M | $31.3B | ||
| Q4 24 | $707.5M | $29.6B | ||
| Q3 24 | $602.3M | $27.5B | ||
| Q2 24 | $480.5M | $25.9B | ||
| Q1 24 | $448.1M | $25.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | $-1.3B |
| Free Cash FlowOCF − Capex | $-2.5M | $-1.3B |
| FCF MarginFCF / Revenue | -0.4% | -106.4% |
| Capex IntensityCapex / Revenue | 10.3% | 1.3% |
| Cash ConversionOCF / Net Profit | 2.98× | -9.08× |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | $3.5B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $61.3M | $-1.3B | ||
| Q3 25 | $148.7M | $3.5B | ||
| Q2 25 | $-19.1M | $1.5B | ||
| Q1 25 | $109.1M | $-154.5M | ||
| Q4 24 | $86.4M | $-477.8M | ||
| Q3 24 | $85.3M | $192.6M | ||
| Q2 24 | $53.6M | $-622.1M | ||
| Q1 24 | $25.8M | $784.0M |
| Q4 25 | $-2.5M | $-1.3B | ||
| Q3 25 | $79.3M | $3.5B | ||
| Q2 25 | $-69.5M | $1.5B | ||
| Q1 25 | $50.1M | $-169.8M | ||
| Q4 24 | $59.5M | $-491.4M | ||
| Q3 24 | $79.4M | $175.9M | ||
| Q2 24 | $47.6M | $-640.5M | ||
| Q1 24 | $11.8M | $766.6M |
| Q4 25 | -0.4% | -106.4% | ||
| Q3 25 | 13.2% | 10.7% | ||
| Q2 25 | -12.8% | 173.3% | ||
| Q1 25 | 8.5% | -20.7% | ||
| Q4 24 | 12.4% | -74.1% | ||
| Q3 24 | 19.8% | 0.6% | ||
| Q2 24 | 15.1% | -112.0% | ||
| Q1 24 | 4.3% | 150.5% |
| Q4 25 | 10.3% | 1.3% | ||
| Q3 25 | 11.6% | 0.1% | ||
| Q2 25 | 9.3% | 1.9% | ||
| Q1 25 | 10.1% | 1.9% | ||
| Q4 24 | 5.6% | 2.1% | ||
| Q3 24 | 1.5% | 0.1% | ||
| Q2 24 | 1.9% | 3.2% | ||
| Q1 24 | 5.0% | 3.4% |
| Q4 25 | 2.98× | -9.08× | ||
| Q3 25 | 9.43× | 41.18× | ||
| Q2 25 | -0.45× | 23.52× | ||
| Q1 25 | 2.20× | -2.15× | ||
| Q4 24 | 3.32× | -5.61× | ||
| Q3 24 | 1.13× | 2.51× | ||
| Q2 24 | 4.03× | -10.05× | ||
| Q1 24 | 2.32× | 14.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
